A case of severe COVID-19 pneumonia in pregnancy managed with tofacitinib and review of literature
The incidence of coronavirus disease (COVID-19) is increasing each day worldwide and the clinico-pharmacological dynamics of it is also changing with time. Pregnant women do also get infected though mostly mild to moderate in nature. To date, there is no specific drug against the severe acute respir...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Barpeta Obstetrics and Gynaecological Society
2023-08-01
|
| Series: | New Indian Journal of OBGYN |
| Subjects: | |
| Online Access: | http://journal.barpetaogs.co.in/pdf/010218.pdf |
| Summary: | The incidence of coronavirus disease (COVID-19) is increasing each day worldwide and the clinico-pharmacological dynamics of it is also changing with time. Pregnant women do also get infected though mostly mild to moderate in nature. To date, there is no specific drug against the severe acute respiratory syndrome coronavirus disease-2 (SARS-CoV-2), more so its drug management in pregnancy in view of adverse maternal and fetal effects. There are different treatment modalities described in literature. Here, we present a case of severe COVID-19 pneumonia in second trimester pregnancy managed successfully with “off label” use of tofacitinib along with steroid pulse therapy in preventing her from going to invasive mechanical ventilation and probable catastrophe due to hyperinflammatory syndrome characterised by surge of cytokines. |
|---|---|
| ISSN: | 2454-2334 2454-2342 |